anmelden
BX Swiss TOP 30 CHF
1.453,02
PKT
+6,87
PKT
+0,48
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.12.05 | Novartis | DZ-Bank | |
| 16.12.05 | Holcim kaufen | Helaba Trust | |
| 16.12.05 | Novartis halten | National-Bank AG | |
| 20.12.05 | Novartis buy | Jyske Bank | |
| 14.12.05 | Roche verkaufen | Hamburger Sparkasse | |
| 14.12.05 | Lonza halten | Hamburger Sparkasse | |
| 13.12.05 | UBS buy | SRC Research | |
| 09.12.05 | UBS | DZ-Bank | |
| 09.12.05 | Novartis | DZ-Bank | |
| 08.12.05 | UBS equal-weight | Morgan Stanley | |
| 07.12.05 | UBS buy | Merrill Lynch | |
| 02.12.05 | Novartis | DZ-Bank | |
| 02.12.05 | UBS | DZ-Bank | |
| 02.12.05 | Swiss Life overweight | JP Morgan | |
| 01.12.05 | Richemont | Focus Money | |
| 01.12.05 | UBS | Zürcher Kantonalbank | |
| 25.11.05 | Nestlé kaufen | Helaba Trust | |
| 28.11.05 | UBS | DZ-Bank | |
| 28.11.05 | Novartis | DZ-Bank | |
| 29.11.05 | Roche buy | Jyske Bank | |
| 25.11.05 | ABB (Asea Brown Boveri) | Wirtschaftswoche | |
| 24.11.05 | Nestlé akkumulieren | Independent Research | |
| 21.11.05 | UBS | Euro am Sonntag | |
| 18.11.05 | UBS | DZ-Bank | |
| 18.11.05 | Novartis | DZ-Bank | |
| 22.11.05 | Nestlé accumulate | Jyske Bank | |
| 22.11.05 | Roche buy | Jyske Bank | |
| 18.11.05 | Richemont kaufen | National-Bank AG | |
| 17.11.05 | Zurich Insurance halten | Helaba Trust | |
| 17.11.05 | Novartis | JRC | |
| 16.11.05 | Swiss Life buy | HypoVereinsbank | |
| 15.11.05 | Zurich Insurance halten | Helaba Trust | |
| 15.11.05 | Swiss Life Marketperformer | LB Rheinland-Pfalz | |
| 16.11.05 | Swiss Life kaufen | Nord LB | |
| 15.11.05 | Zurich Insurance buy | Bank Sarasin & Cie | |
| 14.11.05 | Swiss Life buy | Merck Finck & Co | |
| 15.11.05 | Novartis | DZ-Bank | |
| 15.11.05 | UBS | DZ-Bank | |
| 14.11.05 | Swisscom underperform | Goldman Sachs | |
| 10.11.05 | Novartis | Zürcher Kantonalbank |